Nov 25 (Reuters) - Creso Pharma Ltd (CPH) :
- UPDATE ON PRICE AND VOLUME QUERY RESPONSE
- APPEARS TO HAVE BECOME INVOLVED IN ASIC INVESTIGATION BECAUSE OF COMMON DIRECTORSHIPS BETWEEN IT AND EVERBLU CAPITAL
- ADAM BLUMENTHAL OFFERED TO STAND ASIDE FROM HIS ROLE AS CHAIRMAN OF CRESO PHARMA
- EXECUTIVE DIRECTOR JAMES ELLINGFORD WILL ACT AS INTERIM CHAIRMAN OF CO
- BOARD ESTABLISHED A STANDALONE SUB-COMMITTEE TO ADDRESS & RESPOND TO ASIC NOTICE
News: CPH Creso Pharma Updates On Price And Volume Query Response
Add to My Watchlist
What is My Watchlist?